Position in TKNO
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$21,537
+$16,526 QoQ
Shares Held
3,792
+118.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 80 holders
Holding Since
Jun 2021
9 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in TKNO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $362,370,004 across 49 Drug Manufacturers - Specialty & Generic names. TKNO ranks #43 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
893,500 | $64,206,902 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
329,065 | $55,460,607 | |
| 3 | VTRS |
Viatris Inc
|
3,423,675 | $54,367,956 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
61,355 | $33,243,974 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,112,894 | $27,388,318 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
147,146 | $16,324,370 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
427,444 | $14,481,798 | |
| 8 | ALKS |
Alkermes plc.
|
222,624 | $11,665,496 |
All Filings in TKNO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,537 | 3,792 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $5,011 | 1,734 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $4,829 | 1,271 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,793 | 936 | Shares | Defined | 2025-11-13 | |
| 2022-09-30 | $656,185 | 196,463 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $1,655,068 | 197,032 | Shares | Defined | 2022-07-29 | |
| 2021-12-31 | $4,173,864 | 203,802 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $4,515,369 | 181,413 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $396,812 | 16,722 | Shares | Defined | 2021-08-04 | |
| No filing history on record for this holder in this stock. | ||||||